StockData
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. (JSPR) stock

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$10.34−1.43 (-12.15%)

Close on Nov 17, 2026Market cap $344.06MP/E –Yield –

Jasper Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Jasper Therapeutics

Jasper Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Jasper Therapeutics figures

See a number that looks wrong?